trending Market Intelligence /marketintelligence/en/news-insights/trending/nbzmofqtbtjayq8ltff6og2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

Thank you for your interest in S&P Global Market Intelligence! We noticed you've identified yourself as a student. Through existing partnerships with academic institutions around the globe, it's likely you already have access to our resources. Please contact your professors, library, or administrative staff to receive your student login.

At this time we are unable to offer free trials or product demonstrations directly to students. If you discover that our solutions are not available to you, we encourage you to advocate at your university for a best-in-class learning experience that will help you long after you've completed your degree. We apologize for any inconvenience this may cause.

In This List

Intec Pharma raises $2M from underwriters of its public offering

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry


IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

The Market Intelligence Platform

Intec Pharma raises $2M from underwriters of its public offering

Intec Pharma Ltd. said the underwriters of its public offering partially exercised their overallotment option to buy 400,000 additional shares at $5.25 apiece.

The Israel-based clinical stage biopharmaceutical company received net proceeds of about $2 million from the exercise.

In April, Intec closed its public offering of 6.75 million ordinary shares at $5.25 apiece to raise about $35.4 million in gross proceeds.

Oppenheimer & Co. Inc. acted as the sole book-running manager, while Ladenburg Thalmann and Roth Capital Partners acted as co-managers in the offering.